Search Results - "KANNO, Yoshihiko"

Refine Results
  1. 1

    Blood pressure management in patients receiving renal replacement therapy by Kanno, Yoshihiko

    Published in Hypertension research (01-01-2021)
    “…Hypertension is the most common complication of kidney disease, diabetes, and other cardiovascular diseases. In addition, it is a critical factor in the…”
    Get full text
    Journal Article
  2. 2
  3. 3

    A new nutritional risk index for predicting mortality in hemodialysis patients: Nationwide cohort study by Kanda, Eiichiro, Kato, Akihiko, Masakane, Ikuto, Kanno, Yoshihiko

    Published in PloS one (28-03-2019)
    “…Protein energy wasting (PEW) is a risk factor for death. However, the cutoff vales for PEW are not optimized for early identification of hemodialysis patients…”
    Get full text
    Journal Article
  4. 4

    Uric acid level has a U-shaped association with loss of kidney function in healthy people: a prospective cohort study by Kanda, Eiichiro, Muneyuki, Toshitaka, Kanno, Yoshihiko, Suwa, Kaname, Nakajima, Kei

    Published in PloS one (06-02-2015)
    “…The relationship between hyperuricemia and chronic kidney disease (CKD) has been found in various observational studies. Although hypouricemia is associated…”
    Get full text
    Journal Article
  5. 5

    Identifying progressive CKD from healthy population using Bayesian network and artificial intelligence: A worksite-based cohort study by Kanda, Eiichiro, Kanno, Yoshihiko, Katsukawa, Fuminori

    Published in Scientific reports (25-03-2019)
    “…Identifying progressive early chronic kidney disease (CKD) patients at a health checkup is a good opportunity to improve their prognosis. However, it is…”
    Get full text
    Journal Article
  6. 6

    Comparison of accuracy between pre-hemodialysis and post-hemodialysis levels of nutritional factors for prediction of mortality in hemodialysis patients by Kanno, Yoshihiko, Kanda, Eiichiro

    Published in Clinical nutrition (Edinburgh, Scotland) (01-02-2019)
    “…The nutritional status of hemodialysis (HD) patients is usually assessed using pre-HD laboratory data. However, it remains unclear whether the most diluted…”
    Get full text
    Journal Article
  7. 7

    COVID‐19 of dialysis patients in Japan: Current status and guidance on preventive measures by Kikuchi, Kan, Nangaku, Masaomi, Ryuzaki, Munekazu, Yamakawa, Tomoyuki, Hanafusa, Norio, Sakai, Ken, Kanno, Yoshihiko, Ando, Ryoichi, Shinoda, Toshio, Nakamoto, Hidetomo, Akizawa, Tadao

    Published in Therapeutic apheresis and dialysis (01-08-2020)
    “…In Japan, the first case of COVID‐19 in dialysis patients was reported on March 1, 2020. A total of 31 cases were reported by April 10, and it increased to 95…”
    Get full text
    Journal Article
  8. 8

    Methods and Nutritional Interventions to Improve the Nutritional Status of Dialysis Patients in JAPAN-A Narrative Review by Kanno, Yoshihiko, Kanda, Eiichiro, Kato, Akihiko

    Published in Nutrients (21-04-2021)
    “…Patients receiving dialysis therapy often have frailty, protein energy wasting, and sarcopenia. However, medical staff in Japan, except for registered…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Effectiveness of SARS‐CoV‐2 vaccines on hemodialysis patients in Japan: A nationwide cohort study by Kikuchi, Kan, Nangaku, Masaomi, Ryuzaki, Munekazu, Yamakawa, Tomoyuki, Yoshihiro, Ota, Hanafusa, Norio, Sakai, Ken, Kanno, Yoshihiko, Ando, Ryoichi, Shinoda, Toshio, Wakino, Shu, Nakamoto, Hidetomo, Takemoto, Yoshiaki, Akizawa, Tadao

    Published in Therapeutic apheresis and dialysis (01-02-2023)
    “…Introduction This study compared the outcomes of dialysis patients who received SARS‐CoV‐2 vaccine with those who did not use data from the Japanese COVID‐19…”
    Get full text
    Journal Article
  11. 11

    Structural changes in renal arterioles are closely associated with central hemodynamic parameters in patients with renal disease by Miyaoka, Yoshitaka, Okada, Tomonari, Tomiyama, Hirofumi, Morikawa, Atsuko, Rinno, Sho, Kato, Miho, Tsujimoto, Ryuji, Suzuki, Rie, China, Rieko, Nagai, Miho, Nagaoka, Yume, Nagao, Toshitaka, Kanno, Yoshihiko

    Published in Hypertension research (01-09-2021)
    “…Although central hemodynamics are known to be closely associated with microvascular damage, their association with lesions in the small renal arteries has not…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16

    Long-term body composition changes in patients undergoing hemodialysis: a single-center retrospective study by Seto, Yumi, Kimura, Mina, Matsunaga, Tomohito, Miyasita, Eishi, Kanno, Yoshihiko

    Published in Renal replacement therapy (08-11-2022)
    “…BackgroundPatients undergoing dialysis experience substantial decreases in muscle mass and functional muscle weakness. Muscle mass loss in patients undergoing…”
    Get full text
    Journal Article
  17. 17

    A report of three cases of patients with tubulointerstitial nephritis with IgM-positive plasma cells, treatment, and serum-IgM as a sensitive marker for relapse by Akagi, Ryota, Ishii, Akira, Kaneko, Keiichi, Kondo, Naoya, Yokoi, Hideki, Matsubara, Takeshi, Minamiguchi, Sachiko, Kanno, Yoshihiko, Yanagita, Motoko

    Published in BMC nephrology (04-07-2023)
    “…Tubulointerstitial nephritis with IgM-positive plasma cells (IgMPC-TIN) is a newer disease about which there are many unclear points. Glucocorticoid therapy is…”
    Get full text
    Journal Article
  18. 18

    Survival and predictive factors in dialysis patients with COVID-19 in Japan: a nationwide cohort study by Kikuchi, Kan, Nangaku, Masaomi, Ryuzaki, Munekazu, Yamakawa, Tomoyuki, Yoshihiro, Oota, Hanafusa, Norio, Sakai, Ken, Kanno, Yoshihiko, Ando, Ryoichi, Shinoda, Toshio, Nakamoto, Hidetomo, Akizawa, Tadao

    Published in Renal replacement therapy (01-01-2021)
    “…The Japanese Association of Dialysis Physicians, the Japanese Society for Dialysis Therapy, and the Japanese Society of Nephrology jointly established COVID-19…”
    Get full text
    Journal Article
  19. 19
  20. 20

    rAAV6-mediated miR-29b delivery suppresses renal fibrosis by Saito, Suguru, Ohno, Shin-ichiro, Harada, Yuichirou, Oikawa, Keiki, Fujita, Koji, Mineo, Shouichirou, Gondo, Asako, Kanno, Yoshihiko, Kuroda, Masahiko

    Published in Clinical and experimental nephrology (01-12-2019)
    “…Background Previous studies showed that microRNA-29b (miR-29b) inhibits renal fibrosis. Therefore, miR-29b replacement therapy represents a promising approach…”
    Get full text
    Journal Article